Skip to main content
OpenTrials
Completed

NCT Number: NCT04376294

Using of Extracorporeal Shockwave Therapy in Treatment Of Achilles Tendinopathy

The purpose of this study was to determine the effect of extracorporeal Shock wave therapy (ESWT) on functional activity and pain in patients with Achilles tendinopathy

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Achilles Tendinopathy

Age range

18 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Cairo university

Giza, Egypt

About this study

Fifty patients of both sexes with Achilles tendinopathy aged 18-40 years, were assigned randomly into two equal groups. The study group received ESWT in addition to a conservative physical therapy program for four weeks, while the control group received a conservative physical therapy program only. Pain and functional mobility were assessed before and after treatment through a visual analog scale (VAS) and Victorian Institute of sports assessment - Achilles questionnaire (VISA-A), respectively

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical history of Achilles tendon pain for at least six months
  • A minimum of three months conservative treatment administered without benefit for at least four weeks before ESWT.

Exclusion criteria

  • Patients underwent physical therapy in the four weeks prior enrollment to study.
  • Patients had taken non-steroidal anti-inflammatory medication during the previous week
  • Patients had received peritendinous injections of a local anesthetic or corticosteroid within last 4 weeks
  • Patients had bilateral Achilles tendinopathy
  • Patients with other conditions that could significantly contribute to posterior ankle pain (osteoarthritis, radiculopathy, systemic neurologic conditions)
  • Patients having previous injury or surgical treatments of the ankle.

Treatment and study plan

Extracorporeal Shockwave Therapy(ESWT)

Device

Each session of Extracorporeal Shockwave Therapy(ESWT) consists of 2000 pulses with a pressure of 3 bars (equals an energy flux density of 0.1 mJ/mm²), and treatment frequency of 8 pulses/sec

Eccentric training of the calf muscle:

Other

The patients were asked to stand with all their body weight on the injured leg on a wooden step. From an upright body position and standing with all body weight on the forefoot, with the ankle joint in plantar flexion. The calf muscle is loaded by having the patient lower the affected limb down by dorsiflexion the ankle until the plantar aspect of the heel lay below the level of the step, and the ankle is in maximum dorsiflexion.

Gastrocnemius, soleus, and hamstring stretch

Other

Stretching every muscle for 30 seconds. Each stretch was performed 3 times (holding for 30 seconds and rest for 30 seconds). All these stretches were performed directly after the eccentric exercises twice/day for 7 days/week for weeks

Primary outcomes

  1. The Victorian Institute of Sport Assessment-Achilles questionnaire (VISA-A).

    Time frame: 15 minutes

    It consists of eight questions that covered the three domains of pain (questions 1-3), function (questions 4-6), and activity (questions 7 and 8.). Questions one to seven are scored out of 10, and question 8 carries a maximum of 30. Scores are summed to give a total out of 100.

Secondary outcomes

  1. The visual analog scale (VAS).

    Time frame: 15 minutes

    The VAS is a continuous scale consists of a horizontal line (HVAS) usually 10 centimeters (10-100 mm) in length. For pain intensity, the scale is most anchored by no pain (score of 0) and pain as bad as it could be or worst imaginable pain (score of 10

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Collaborators

  • Mr.Mohamed Nasser Kise Helmy
  • Prof.Dr Nadia Abdelazim fayaz
  • Prof.Dr. Emad Samuel Boles Saweeres

Registry information

Important dates

Study start
2018
Primary completion
2018
Study completion
2020
First posted
May 6, 2020
Registry last updated
Jul 17, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.